Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
1758881000168119 | bupivacaine hydrochloride monohydrate 20 mg / 4 mL + glucose monohydrate 320 mg / 4 mL injection, 4 mL ampoule (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
1758891000168116 | bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL injection, ampoule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL injection, ampoule | Is a | medicinal product unit of use | false | Inferred relationship | Some | ||
bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL injection, ampoule | Is a | bupivacaine + glucose | false | Inferred relationship | Some | ||
bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL injection, ampoule | Is a | bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) injection, ampoule | false | Inferred relationship | Some | ||
bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL injection, ampoule | has manufactured dose form | injection | false | Inferred relationship | Some | ||
bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL injection, ampoule | has unit of use | ampoule | false | Inferred relationship | Some | 1853678720 | |
bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL injection, ampoule | has intended active ingredient | glucose | false | Inferred relationship | Some | 1392699075 | |
bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL injection, ampoule | has Australian BoSS | glucose monohydrate | false | Inferred relationship | Some | 1392699075 | |
bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL injection, ampoule | has intended active ingredient | bupivacaine | false | Inferred relationship | Some | 1853678719 | |
bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL injection, ampoule | has Australian BoSS | bupivacaine hydrochloride monohydrate | false | Inferred relationship | Some | 1853678719 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Marcain Spinal Heavy injection, 4 mL ampoule | Is a | False | bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL injection, ampoule | Inferred relationship | Some | |
bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL injection, 5 x 4 mL ampoules | has MPUU | False | bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL injection, ampoule | Inferred relationship | Some | 1 |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set